---
layout: page
title: Publications
published: true
---

### Estrogen receptors
[Zhu J, Zhao C, Kharman-biz A, _et al_. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation. Oncogene. 2014.](http://www.ncbi.nlm.nih.gov/pubmed/?term=24441041)

[Katchy A, Pinto C, Jonsson P, _et al_. Coexposure to phytoestrogens and bisphenol a mimics estrogenic effects in an additive manner. Toxicol Sci. 2014;138(1):21-35.](http://www.ncbi.nlm.nih.gov/pubmed/?term=24284790)

[Jonsson P, Katchy A, Williams C. Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells. Endocr Relat Cancer. 2014;21(2):143-60.](http://www.ncbi.nlm.nih.gov/pubmed/?term=24192230)

[Dey P, Jonsson P, Hartman J, Williams C, Ström A, Gustafsson JÅ. Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. Mol Endocrinol. 2012;26(12):1991-2003.](http://www.ncbi.nlm.nih.gov/pubmed/?term=23028063)

[Dahlman-wright K, Qiao Y, Jonsson P, Gustafsson JÅ, Williams C, Zhao C. Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells. Carcinogenesis. 2012;33(9):1684-91.](http://www.ncbi.nlm.nih.gov/pubmed/?term=22791811)

[Edvardsson K, Ström A, Jonsson P, Gustafsson JÅ, Williams C. Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells. Mol Endocrinol. 2011;25(6):969-79.](http://www.ncbi.nlm.nih.gov/pubmed/?term=21493669)

[Alvarez-baron CP, Jonsson P, Thomas C, Dryer SE, Williams C. The two-pore domain potassium channel KCNK5: induction by estrogen receptor alpha and role in proliferation of breast cancer cells. Mol Endocrinol. 2011;25(8):1326-36.](http://www.ncbi.nlm.nih.gov/pubmed/?term=21680658)  
* * *
### Other nuclear receptors
[Candelaria NR, Addanki S, Zheng J, _et al_. Antiproliferative effects and mechanisms of liver x receptor ligands in pancreatic ductal adenocarcinoma cells. PLoS ONE. 2014;9(9):e106289.](http://www.ncbi.nlm.nih.gov/pubmed/?term=25184494)

[Nguyen-Vu T, Vedin LL, Liu K, _et al_. Liver X receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism. Breast Cancer Res. 2013;15(3):R51.](http://www.ncbi.nlm.nih.gov/pubmed/?term=23809258)

[Ehrlund A, Jonsson P, Vedin LL, Williams C, Gustafsson JÅ, Treuter E. Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFβ, and Wnt/β-catenin signaling in adrenocortical carcinoma cells. PLoS ONE. 2012;7(3):e32080.](http://www.ncbi.nlm.nih.gov/pubmed/?term=22427816)

### Misc.
[Wang J, Tsouko E, Jonsson P, _et al_. miR-206 inhibits cell migration through direct targeting of the actin-binding protein Coronin 1C in triple-negative breast cancer. Mol Oncol. 2014.](http://www.ncbi.nlm.nih.gov/pubmed/?term=25074552)

[Zhao C, Qiao Y, Jonsson P, _et al_. Genome-wide Profiling of AP-1-Regulated Transcription Provides Insights into the Invasiveness of Triple-Negative Breast Cancer. Cancer Res. 2014;74(14):3983-94.](http://www.ncbi.nlm.nih.gov/pubmed/?term=24830720)